Go Deep
BioSyent Inc.
BioSyent Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 20,812 | 19.6 | 4.09 | 0.07 | 1,134.24 |
BioSyent Inc. Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 19,872,763.0 | 13,908,182.0 | 9,671,923.0 | 12,221,804.0 |
| Net Profit | 2,849,437.0 | 2,344,819.0 | 1,991,788.0 | 2,682,340.0 |
| EPS | 0.2 | 0.2 | 0.2 | 0.2 |
BioSyent Inc. Revenue & Profit: Last 5 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Revenue | 43,051,983.0 | 35,030,897.0 | 31,590,302.0 | 27,925,187.0 | — |
| Net Profit | 9,012,232.0 | 7,270,104.0 | 6,460,127.0 | 5,458,345.0 | — |
| EPS | 0.8 | 0.6 | 0.5 | 0.4 | — |
BioSyent Inc. Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Total Assets | 49,439,459.0 | 41,359,450.0 | 41,528,939.0 | 40,485,264.0 |
| Total Liabilities | 7,973,953.0 | 6,356,265.0 | 6,769,183.0 | 7,122,741.0 |
| Total Equity | 41,465,506.0 | 35,003,185.0 | 34,759,756.0 | 33,362,523.0 |
BioSyent Inc. Assets & Liabilities Breakdown (CAD millions)
What it owns — Dec 2025
Cash & short-term investments 58.0%Receivables 9.2%Inventory 13.0%Fixed assets (tangible) 2.0%Intangible assets 9.7%Long-term investments 6.7%Other assets 1.5%
How it's funded — Dec 2025
Long-term debt 1.3%Payables 12.4%Other liabilities 2.0%Shareholders' equity 83.9%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 28.7 | 15.9 | 26.2 | 28.7 |
| Receivables | 4.5 | 3.0 | 3.5 | 3.7 |
| Inventory | 6.4 | 5.3 | 5.9 | 4.5 |
| Fixed assets (tangible) | 1.0 | 1.2 | 1.4 | 1.7 |
| Intangible assets | 4.8 | 5.0 | 1.2 | 1.2 |
| Long-term investments | 3.3 | 10.1 | 2.5 | 0.0 |
| Other assets | 0.8 | 0.8 | 0.8 | 0.7 |
| Liabilities & equity | ||||
| Short-term debt | 0.2 | 0.2 | 0.2 | 0.2 |
| Long-term debt | 0.6 | 0.8 | 1.0 | 1.2 |
| Payables | 6.1 | 4.0 | 5.1 | 5.1 |
| Other liabilities | 1.0 | 1.3 | 0.5 | 0.7 |
| Shareholders' equity | 41.5 | 35.0 | 34.8 | 33.4 |
| Net tangible assets | 36.7 | 30.0 | 33.6 | 32.2 |
BioSyent Inc. Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | 9,009,146.0 | 8,663,484.0 | 5,054,974.0 | 4,948,756.0 | — |
| Investing Activities | 4,092,668.0 | 3,288,020.0 | 883,847.0 | -10,790,099.0 | — |
| Financing Activities | -3,407,391.0 | -7,828,563.0 | -5,784,535.0 | -4,371,489.0 | — |